Evidence map›Paper›PMID 32595146›Full record

ArticleBMJ open2020

Hospitalisation at the end of life among cancer and non-cancer patients in Denmark: a nationwide register-based cohort study.

Anne Høy Seemann Vestergaard, Mette Asbjoern Neergaard, Christian Fynbo Christiansen, Henrik Nielsen, Thomas Lyngaa, Kristina Grønborg Laut, Søren Paaske Johnsen

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anne Høy Seemann VestergaardDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-5140-1803
Mette Asbjoern NeergaardThe Palliative Care Team, Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Christian Fynbo ChristiansenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Henrik NielsenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Thomas LyngaaDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Kristina Grønborg LautDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Søren Paaske JohnsenDanish Center for Clinical Health Services Research, Aalborg University, Aalborg, Denmark soeren.johnsen@rn.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEnd-of-life hospitalisations may not be associated with improved quality of life. Studies indicate differences in end-of-life care for cancer and non-cancer patients; however, data on hospital utilisation are sparse. This study aimed to compare end-of-life hospitalisation and place of death among patients dying from cancer, heart failure or chronic obstructive pulmonary disease (COPD).

designA nationwide register-based cohort study.

settingData on all in-hospital admissions obtained from nationwide Danish medical registries.

participantsAll decedents dying from cancer, heart failure or COPD disease in Denmark between 2006 and 2015. OUTCOME MEASURES: Data on all in-hospital admissions within 6 months and 30 days before death as well as place of death. Comparisons were made according to cause of death while adjusting for age, sex, comorbidity, partner status and residential region.

resultsAmong 154 235 decedents, the median total bed days in hospital within 6 months before death was 19 days for cancer patients, 10 days for patients with heart failure and 11 days for patients with COPD. Within 30 days before death, this was 9 days for cancer patients, and 6 days for patients with heart failure and COPD. Compared with cancer patients, the adjusted relative bed day use was 0.65 (95% CI, 0.63 to 0.68) for heart failure patients and 0.68 (95% CI, 0.66 to 0.69) for patients with COPD within 6 months before death. Correspondingly, this was 0.65 (95% CI, 0.63 to 0.68) and 0.70 (95% CI, 0.68 to 0.71) within 30 days before death.Patients had almost the same risk of dying in hospital independently of death cause (46.2% to 56.0%).

conclusionPatients with cancer, heart failure and COPD all spent considerable part of their end of life in hospital. Hospital use was highest among cancer patients; however, absolute differences were small.

Indexed as

HospitalizationTerminal CareAgedAged, 80 and overDenmarkFemaleHeart FailureHumansMaleMiddle AgedNeoplasmsPulmonary Disease, Chronic ObstructiveQuality of LifeRegistrieschronic diseasedeathhospitalneoplasmspalliative careterminal care

Identifiers

PMID32595146
PMCPMC7322325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.